Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to investigate the feasibility and efficacy of the v-NOTES approach for extremely obese patients with early-stage type 1 endometrial cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| extremely obese patients with early-stage endometrial cancer |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Transvaginal natural orifice endoscopic surgery for endometrial cancer staging | Procedure | Cases of extreme obese patients with early stage endometrial cancer who underwent v-NOTES |
| Measure | Description | Time Frame |
|---|---|---|
| Operating time | The operation time in minutes. The operation time was from commencement of the colpotomy incision to vaginal closure. | 4 hours |
| Any conversion to conventional laparoscopy or laparotomy | Number of the patients whose surgery couldn't completed by transvaginal natural orifice surgery. | 4 hours |
| Pre- and post-operative hemoglobin levels | Hemoglobin levels in g/dL. Hemoglobin levels of the patients before surgery and on postoperative day 1. | 24 hours |
| Length of hospital stay | Length of hospital stay in days. Duration of hospital stay was calculated from the patient's admission until hospital discharge. | 2 day |
| Any intra- or post-operative complication | Number of the patients who have any complication during or after transvaginal natural orifice surgery. | 6 months |
| pain scores | Pain scores in VAS score. Pain scores were evaluated using a visual analog scale (VAS). Scores are based on self-reported measures of pain that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale-"no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10 cm). | 6 hours |
| pain scores |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Extreme obese patients with early stage type-1 endometrial cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ahmet Kale, Prof.Dr. | Kartal Dr.Lutfi Kirdar Research and Training Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Health Sciences Kartal Dr. Lütfi Kirdar Training and Research Hospital | Istanbul | Kartal | 34890 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pain scores in VAS score. Pain scores were evaluated using a visual analog scale (VAS). Scores are based on self-reported measures of pain that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale-"no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10 cm).
| 12 hours |
| pain scores | Pain scores in VAS score. Pain scores were evaluated using a visual analog scale (VAS). Scores are based on self-reported measures of pain that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale-"no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10 cm). | 24 hours |
| ID | Term |
|---|---|
| D016889 | Endometrial Neoplasms |
| D009767 | Obesity, Morbid |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided